Neutrophil gelatinase-associated lipocalin levels are associated with skin thickness and metabolic syndrome features in patients with systemic sclerosis
NGAL serum levels in patients with SSc correlate positively and independently with extension of the skin involvement. NGAL levels also correlate with features of metabolic syndrome, such as a dyslipidaemic pattern and reduced insulin sensitivity, which may be associated with an increased risk of atherosclerosis and cardiovascular disease in patients with SSc.
Authors
- Mónica Renuncio‐García (ORCID: https://orcid.org/0000-0001-8991-3241)
- Iván Ferraz‐Amaro (ORCID: https://orcid.org/0000-0003-0197-5267)
- Santos Castañeda (ORCID: https://orcid.org/0000-0002-7748-853X)
- Miguel Ángel González-Gay (ORCID: https://orcid.org/0000-0002-7924-7406)
- Javier Gonzalo Ocejo-Vinyals (ORCID: https://orcid.org/0000-0003-2245-4639)
- Esther F. Vicente‐Rabaneda (ORCID: https://orcid.org/0000-0001-6823-4194)
- Zena Ibrahim-Achi
- Antonia de Vera-González (ORCID: https://orcid.org/0000-0003-3179-6673)
Institutions
- Universidad de La Laguna (ES)
- Hospital Universitario de Canarias (ES)
- Instituto de Investigación Marqués de Valdecilla (ES)
- Hospital Universitario Fundación Jiménez Díaz (ES)
- Hospital Universitario de La Princesa (ES)
Publication Details
- Journal
- Clinical and Experimental Rheumatology
- Published
- 2024-08-12
- DOI
- https://doi.org/10.55563/clinexprheumatol/lad3qd
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- Sanofi
- Celgene
- European Commission
- Instituto de Salud Carlos III